Please assess the completion status of the following clinical trial:

Trial Title: Control of Epistaxis With Surgiflo

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with epistaxis in emergency room.~* Epistaxis does not stop with anterior nasal packing.~Exclusion Criteria:~* Pregnancy~* Allergy or intolerance to any component of Surgiflo.~* Septal perforation.~* Nasal surgery within 3 months previous to epistaxis.~* Patients admitted to hospital for other reasons.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Nasal catheter (Type: ACTIVE_COMPARATOR): In this arm will be the patients with epistaxis that cannot be stopped with anterior nasal packing and are randomized not to put Surgiflo. So they receive the usual treatment with a nasal catheter balloon into the nose.
- Surgiflo (Type: EXPERIMENTAL): In this arm will be the patients with epistaxis that cannot be stopped with anterior nasal packing and are randomized to put into the nose Surgiflo.

Based on this trial design, predict the completion outcome and termination type (if applicable).